BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804
|
US Biomax |
|
160.00€ |
|
Pub |
ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278.00€ |
|
Pub |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160.00€ |
|
Pub |
PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010
|
US Biomax |
|
231.00€ |
|
Pub |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160.00€ |
|
Pub |
BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456.00€ |
|
Pub |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246
|
US Biomax |
|
88.00€ |
|
Pub |
BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722
|
US Biomax |
|
160.00€ |
|
Pub |
BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231.00€ |
|
Pub |
BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314.00€ |
|
Pub |
IC00011 |
Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b
|
US Biomax |
|
231.00€ |
|
Pub |
BS03013 |
Hepatocellular carcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160.00€ |
|
Pub |
CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b
|
US Biomax |
|
278.00€ |
|
Pub |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160.00€ |
|
Pub |
LV8013 |
Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803
|
US Biomax |
|
231.00€ |
|
Pub |
BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726
|
US Biomax |
|
231.00€ |
|
Pub |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231.00€ |
|
Pub |
BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726
|
US Biomax |
|
160.00€ |
|
Pub |
BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160.00€ |
|
Pub |
BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804
|
US Biomax |
|
231.00€ |
|
Pub |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160.00€ |
|
Pub |
CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602
|
US Biomax |
|
231.00€ |
|
Pub |
BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809
|
US Biomax |
|
160.00€ |
|
Pub |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160.00€ |
|
Pub |
LV721 |
Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160.00€ |
|
Pub |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456.00€ |
|
Pub |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160.00€ |
|
Pub |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax |
|
231.00€ |
|
Pub |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293.00€ |
|
Pub |
LV1501 |
Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160.00€ |
|
Pub |
LV631 |
Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231.00€ |
|
Pub |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231.00€ |
|
Pub |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BS05041 |
Colon adenocarcinoma (grade III) tissue array, 23 cases 63 cores, replaced by CO725
|
US Biomax |
|
189.00€ |
|
Pub |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88.00€ |
|
Pub |
LC803 |
Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array
|
US Biomax |
|
231.00€ |
|
Pub |
PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953
|
US Biomax |
|
314.00€ |
|
Pub |
BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129
|
US Biomax |
|
189.00€ |
|
Pub |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2
|
US Biomax |
|
278.00€ |
|
Pub |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278.00€ |
|
Pub |
LC991 |
Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OV1001 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005
|
US Biomax |
|
231.00€ |
|
Pub |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88.00€ |
|
Pub |
GI481 |
GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b
|
US Biomax |
|
278.00€ |
|
Pub |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
LC641 |
Non small cell lung carcinoma (NSCLC) tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231.00€ |
|
Pub |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516.00€ |
|
Pub |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045
|
US Biomax |
|
88.00€ |
|
Pub |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266.00€ |
|
Pub |
FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information
|
US Biomax |
|
456.00€ |
|
Pub |
PE801 |
Penile (penis) carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
BC04013 |
Non small cell lung carcinoma tissue array, 63 cases 63 core, replaced by LC806
|
US Biomax |
|
160.00€ |
|
Pub |
UT802 |
Uteral cancer (multi types of uterine carcinomas and diseases) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278.00€ |
|
Pub |
FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999
|
US Biomax |
|
314.00€ |
|
Pub |
BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702
|
US Biomax |
|
231.00€ |
|
Pub |
GL805 |
Glioblastoma multiforme (GBM) tissue array, 40 cases 80 cores, replaced by GL806
|
US Biomax |
|
266.00€ |
|
Pub |
LC1005 |
Lung carcinoma progression tissue array, 77 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802
|
US Biomax |
|
231.00€ |
|
Pub |
BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LV208 |
Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info
|
US Biomax |
|
456.00€ |
|
Pub |
BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018
|
US Biomax |
|
160.00€ |
|
Pub |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
LC481 |
Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS05031 |
Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724
|
US Biomax |
|
160.00€ |
|
Pub |
LV802 |
Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801
|
US Biomax |
|
189.00€ |
|
Pub |
BS36011 |
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803
|
US Biomax |
|
266.00€ |
|
Pub |
LC802 |
Lung small cell carcinoma tissue array (40 cases 80 cores)
|
US Biomax |
|
266.00€ |
|
Pub |
NPC962 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC961, 96 cases 96 cores
|
US Biomax |
|
308.00€ |
|
Pub |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386
|
US Biomax |
|
88.00€ |
|
Pub |
BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962
|
US Biomax |
|
231.00€ |
|
Pub |
BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BO242 |
Human normal bone tissue array, 12 cases 24 cores, replaced by BO243
|
US Biomax |
|
100.00€ |
|
Pub |
BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b
|
US Biomax |
|
231.00€ |
|
Pub |
LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231.00€ |
|
Pub |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724
|
US Biomax |
|
160.00€ |
|
Pub |
NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
SM801 |
Small intestine carcinoma and normal tissue array, 77 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ES801 |
Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010
|
US Biomax |
|
231.00€ |
|
Pub |
BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
MO32011 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replaced by MO1002
|
US Biomax |
|
189.00€ |
|
Pub |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD811 |
Renal carcinoma and normal tissue array, with TNM, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PA207 |
High density (69 cases 207 cores), multiple pancreatic cancer (1 3 grade) and normal pancreatic tissue array, replaced by PA2072
|
US Biomax |
|
456.00€ |
|
Pub |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax |
|
160.00€ |
|
Pub |
LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax |
|
231.00€ |
|
Pub |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax |
|
160.00€ |
|
Pub |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO812 |
Colon carcinoma and normal tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631
|
US Biomax |
|
160.00€ |
|
Pub |
BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b
|
US Biomax |
|
160.00€ |
|
Pub |
PA241 |
Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b
|
US Biomax |
|
100.00€ |
|
Pub |
BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax |
|
88.00€ |
|
Pub |
BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804
|
US Biomax |
|
231.00€ |
|
Pub |
LC801 |
Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores
|
US Biomax |
|
189.00€ |
|
Pub |
NPC961 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC962, >50 cases 96 cores
|
US Biomax |
|
344.00€ |
|
Pub |
BRC491 |
Human breast invasive ductal carcinoma (IDC) tissue array, non overlapping with BRC711, 49 cases 49 cores
|
US Biomax |
|
142.00€ |
|
Pub |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189.00€ |
|
Pub |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278.00€ |
|
Pub |
BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS01042 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723
|
US Biomax |
|
160.00€ |
|
Pub |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BS05021 |
Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723
|
US Biomax |
|
160.00€ |
|
Pub |
BS06031 |
Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723
|
US Biomax |
|
160.00€ |
|
Pub |
BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014
|
US Biomax |
|
160.00€ |
|
Pub |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962
|
US Biomax |
|
0.00€ |
|
Pub |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044
|
US Biomax |
|
88.00€ |
|
Pub |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T391 |
Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392
|
US Biomax |
|
88.00€ |
|
Pub |
OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456.00€ |
|
Pub |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax |
|
278.00€ |
|
Pub |
KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MC962 |
Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99.00€ |
|
Pub |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803
|
US Biomax |
|
231.00€ |
|
Pub |
NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
PR804 |
Hyperplasia and carcinoma of prostate tissue array, 80 cases 80 cores, with grade and Gleason score information
|
US Biomax |
|
266.00€ |
|
Pub |
BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803
|
US Biomax |
|
160.00€ |
|
Pub |
LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013
|
US Biomax |
|
231.00€ |
|
Pub |
MC5001 |
High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002
|
US Biomax |
|
634.00€ |
|
Pub |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722
|
US Biomax |
|
160.00€ |
|
Pub |
BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804
|
US Biomax |
|
231.00€ |
|
Pub |
T194 |
Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR805 |
Breast infiltrating lobular carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601
|
US Biomax |
|
231.00€ |
|
Pub |
ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004
|
US Biomax |
|
266.00€ |
|
Pub |
MC242 |
Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245
|
US Biomax |
|
88.00€ |
|
Pub |
BR2001 |
Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086
|
US Biomax |
|
456.00€ |
|
Pub |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NPC481 |
Nasopharyngeal carcinoma tissue array, 48 cases 49 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores
|
US Biomax |
|
189.00€ |
|
Pub |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
T171 |
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases 24 cores, replaced by T174
|
US Biomax |
|
88.00€ |
|
Pub |
LC2082 |
Multiple lung carcinoma and normal tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
BR2085b |
High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast
|
US Biomax |
|
456.00€ |
|
Pub |
SK243 |
Age grouped female skin tissue array, 12 cases 24 cores, replaced by SK244
|
US Biomax |
|
231.00€ |
|
Pub |
SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
PR801 |
Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803
|
US Biomax |
|
231.00€ |
|
Pub |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725
|
US Biomax |
|
160.00€ |
|
Pub |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013
|
US Biomax |
|
231.00€ |
|
Pub |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
PR954 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955
|
US Biomax |
|
456.00€ |
|
Pub |
LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
|
US Biomax |
|
231.00€ |
|
Pub |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964
|
US Biomax |
|
231.00€ |
|
Pub |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336.00€ |
|
Pub |
OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814
|
US Biomax |
|
456.00€ |
|
Pub |
BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a
|
US Biomax |
|
88.00€ |
|
Pub |
SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801
|
US Biomax |
|
231.00€ |
|
Pub |
BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811
|
US Biomax |
|
231.00€ |
|
Pub |
BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483
|
US Biomax |
|
160.00€ |
|
Pub |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558.00€ |
|
Pub |
BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084
|
US Biomax |
|
88.00€ |
|
Pub |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a
|
US Biomax |
|
88.00€ |
|
Pub |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801
|
US Biomax |
|
160.00€ |
|
Pub |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
MC241 |
Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244
|
US Biomax |
|
88.00€ |
|
Pub |
BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
NPC111 |
Nasopharyngeal carcinoma tissue array, 11 cases 11 cores
|
US Biomax |
|
106.00€ |
|
Pub |
LVC2281 |
Liver cancer high density tissue array, 228 cases 228 cores, replaced by LV2161
|
US Biomax |
|
403.00€ |
|
Pub |
ME801 |
Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804
|
US Biomax |
|
231.00€ |
|
Pub |
T381 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385
|
US Biomax |
|
88.00€ |
|
Pub |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
MC541 |
Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542
|
US Biomax |
|
160.00€ |
|
Pub |
OV804 |
Ovarian metastatic carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BS01032 |
Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808
|
US Biomax |
|
160.00€ |
|
Pub |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266.00€ |
|
Pub |
KD482 |
Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LN801 |
Normal lymphatic (lymph node, thymus, spleen, tonsil and appendix) tissue array, 80 cases 80 cores, replaced by LN802
|
US Biomax |
|
231.00€ |
|
Pub |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801
|
US Biomax |
|
160.00€ |
|
Pub |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
LC805 |
Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OM601 |
Metastatic carcinoma of epiploon tissue array, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
PR953 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954
|
US Biomax |
|
456.00€ |
|
Pub |
ST802 |
Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PR241 |
Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243
|
US Biomax |
|
88.00€ |
|
Pub |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88.00€ |
|
Pub |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278.00€ |
|
Pub |
GL802 |
Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax |
|
231.00€ |
|
Pub |
BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax |
|
88.00€ |
|
Pub |
BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
IC03001 |
Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805
|
US Biomax |
|
231.00€ |
|
Pub |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085
|
US Biomax |
|
88.00€ |
|
Pub |
UT803 |
Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MCN601 |
Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602
|
US Biomax |
|
231.00€ |
|
Pub |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231.00€ |
|
Pub |
ME1001 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax |
|
231.00€ |
|
Pub |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231.00€ |
|
Pub |
PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805
|
US Biomax |
|
266.00€ |
|
Pub |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014
|
US Biomax |
|
231.00€ |
|
Pub |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
BS04102 |
Large cell carcinoma of lung tissue array, 21 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status
|
US Biomax |
|
160.00€ |
|
Pub |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
SK481 |
Skin cancer tissue array with corresponding (unmatched) normal adjacent tissues, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119
|
US Biomax |
|
336.00€ |
|
Pub |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
GL242 |
Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
LC487 |
Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
NGL961 |
Nervous system glioma tissue array, 48 cases 96 cores
|
US Biomax |
|
261.00€ |
|
Pub |
PR752 |
Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores
|
US Biomax |
|
485.00€ |
|
Pub |
T005 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN01013 |
Normal stomach tissue (multi sites) array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
TH807 |
Thyroid disease spectrum tissue array, 75 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
KIC481 |
Kidney cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
LV803 |
Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021
|
US Biomax |
|
231.00€ |
|
Pub |
ME207 |
High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal tissues array
|
US Biomax |
|
456.00€ |
|
Pub |
PA242 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
RE804 |
Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC24021 |
Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases 75 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T263 |
Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397.00€ |
|
Pub |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
278.00€ |
|
Pub |
LUD481 |
Lung disease and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242
|
US Biomax |
|
88.00€ |
|
Pub |
OV484 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
T123 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CIN481 |
Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
HE1001 |
Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
NST961 |
Nervous system tumor tissue array, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T033 |
Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BRC711 |
Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores
|
US Biomax |
|
142.00€ |
|
Pub |
CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FRA781 |
FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 cores
|
US Biomax |
|
331.00€ |
|
Pub |
LC1501 |
Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LVC962 |
Liver cancer and normal tissue array, non overlapping with LVC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801
|
US Biomax |
|
266.00€ |
|
Pub |
PA961 |
Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores
|
US Biomax |
|
278.00€ |
|
Pub |
AMS542 |
Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR721 |
Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs
|
US Biomax |
|
231.00€ |
|
Pub |
CO803 |
Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD2083 |
Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV2083 |
High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC6162 |
High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
OV808 |
Ovarian cancer metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
SO8010 |
Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR20826 |
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO1921 |
High density colon cancer tissue array with normal tissues, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES721 |
Esophagus cancer and normal tissue array with TNM and grade info, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
HND181 |
Head and neck disease tissue array, 18 cases 18 cores
|
US Biomax |
|
166.00€ |
|
Pub |
T061 |
Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CVD481 |
Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
LC2085a |
High density (188 cases 208 cores), multiple types of lung cancer (I 3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue
|
US Biomax |
|
456.00€ |
|
Pub |
LY481 |
Lymphatic tissue array, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
MO1601 |
Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011
|
US Biomax |
|
278.00€ |
|
Pub |
STC1502 |
Human stomach cancer mid density tissue array, non overlapping with STC1501 or STC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
TE802 |
Testis seminoma and lymphoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
COC1501 |
Colon cancer mid density tissue array, non overlapping with either COC1502 or COC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
LV483 |
Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
MC809 |
Neuroblastoma and retinoblastoma tissue array, with TNM and grade info, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
RE2081 |
Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ST1001 |
Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T211 |
Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES810 |
Esophagus cancer with matched lymph node metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LP481 |
Larynx and pharynx cancer tissue array with unmatched normal tissues, 48 cases 48, cores with stage and grade data
|
US Biomax |
|
160.00€ |
|
Pub |
OV2082 |
Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T221 |
Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR241 |
Breast cancer test tissue array with self matched or unmatched normal adjacent tissues, 6 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
CO242 |
Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
ESC1501 |
Esophageal cancer mid density tissue array, non overlapping with ESC1502 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LP804 |
Laryngeal cancerous, cancer adjacent and normal tissue array, with grade and stage info, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OV2087 |
Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T101 |
Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
GL801 |
Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NHL482 |
Lymphoma tissue array, 48 cases 48 cores, replacing NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
T011 |
Stomach cancer test tissue array, with TNM and grade info, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
THC961 |
Thyroid cancer tissue array, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax |
|
314.00€ |
|
Pub |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LV808 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ME241 |
Multiple melanoma tissue array with normal tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
PA483 |
Multiple pancreatic cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with grade and stage data
|
US Biomax |
|
160.00€ |
|
Pub |
REC1021 |
Rectum cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
0.00€ |
|
Pub |
ST485 |
Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
T293 |
Bone marrow tumor and normal tissue array, including TNM, 6 cases 24 cores
|
US Biomax |
|
100.00€ |
|
Pub |
CO701 |
Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information
|
US Biomax |
|
231.00€ |
|
Pub |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LV1201 |
Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
397.00€ |
|
Pub |
MC483 |
Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data
|
US Biomax |
|
160.00€ |
|
Pub |
OV641 |
Ovary cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
SM802 |
Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T142 |
Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LC809 |
Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OR2081 |
Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PRC481 |
Prostate cancer tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241
|
US Biomax |
|
88.00€ |
|
Pub |
TR071 |
Rat normal kidney test tissue array, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
MNO341 |
Antibody cross reactivity testing tissue array, 33 cases 34 cores
|
US Biomax |
|
118.00€ |
|
Pub |
BL2082 |
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T413 |
Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO807 |
Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2
|
US Biomax |
|
277.00€ |
|
Pub |
KD2088 |
Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV2088 |
Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC644 |
Multiple cancer tissue array III, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores
|
US Biomax |
|
0.00€ |
|
Pub |
OVC1021 |
Ovary cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
SO804 |
Leiomyosarcoma tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T191 |
Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR20830 |
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801
|
US Biomax |
|
231.00€ |
|
Pub |
LM482 |
Myeloma, lymphoma and normal tissue array, 48 cases 48 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BO801 |
Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CXC961 |
Cervical cancer and normal tissue array, non overlapping with CXC962, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
GIST802 |
Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8
|
US Biomax |
|
296.00€ |
|
Pub |
LC2089 |
Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LYM1502 |
Lymphoma mid density tissue array, non overlapping with LYM1501, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BC000111 |
Multiple organ cancer tissue array, 39 cases 39 cores
|
US Biomax |
|
189.00€ |
|
Pub |
STC962 |
Human stomach cancer and normal tissue array, non overlapping with STC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
COC482 |
Colon cancer and normal tissue array, non overlapping with COC481 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
KD804 |
Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade information
|
US Biomax |
|
231.00€ |
|
Pub |
LV6161 |
High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961
|
US Biomax |
|
266.00€ |
|
Pub |
PA1001 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissues, with TNM data, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
RE482 |
Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ST1502 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
TH802 |
Thyroid cancer and adenoma tissue array, 80 cases 80 cores, no overlaps with TH801
|
US Biomax |
|
231.00€ |
|
Pub |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FFE301 |
Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs 30 cores, replaced by FFE302
|
US Biomax |
|
199.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011
|
US Biomax |
|
231.00€ |
|
Pub |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207
|
US Biomax |
|
456.00€ |
|
Pub |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022
|
US Biomax |
|
231.00€ |
|
Pub |
ST2082 |
High density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC19111 |
Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO481 |
Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ESC961 |
Esophageal cancer tissue array, non overlapping with ESC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
LUC2281 |
High density lung cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
403.00€ |
|
Pub |
MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
SK805 |
Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296.00€ |
|
Pub |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC725 |
Normal lung tissue array, 24 cases 72 cores, replacing BN04011
|
US Biomax |
|
278.00€ |
|
Pub |
NHL803 |
Lymphoma tissue array, 80 cases 80 cores, replacing LM802
|
US Biomax |
|
266.00€ |
|
Pub |
PR806 |
Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN08111 |
Breast hyperplasia and normal tissue array, 10 cases 30 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BRC1502 |
Breast cancer mid density tissue array, non overlapping with either BRC1501 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax |
|
189.00€ |
|
Pub |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LVC1501 |
Liver cancer mid density tissue array, non overlapping with LVC1502 or LVC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ME482 |
Malignant melanoma array with matched normal tissue control, stage and TNM, 48 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
REC481 |
Rectum cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
0.00€ |
|
Pub |
ST801 |
Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |